Bicycle Therapeutics plc
BCYC
$9.69
$0.060.62%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | 38.57% | -71.41% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 38.57% | -71.41% | |||
Cost of Revenue | -233.24% | 19.19% | |||
Gross Profit | 258.80% | -48.49% | |||
SG&A Expenses | -26.71% | 17.88% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 7.29% | 18.77% | |||
Operating Income | -5.98% | -36.87% | |||
Income Before Tax | 2.42% | -36.66% | |||
Income Tax Expenses | 68.62% | -3,098.26% | |||
Earnings from Continuing Operations | -2.07% | -27.60% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -2.07% | -27.60% | |||
EBIT | -5.98% | -36.87% | |||
EBITDA | -6.95% | -37.03% | |||
EPS Basic | -1.97% | 3.83% | |||
Normalized Basic EPS | -7.62% | -1.17% | |||
EPS Diluted | -1.97% | 3.83% | |||
Normalized Diluted EPS | -7.62% | -1.17% | |||
Average Basic Shares Outstanding | 0.09% | 32.69% | |||
Average Diluted Shares Outstanding | 0.09% | 32.69% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |